BALCHEM CORP is 2.2x more valuable than Ingevity Corp by market capitalization ($5.19 B vs $2.37 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NGVT | BCPC |
|---|---|---|
| Market cap | $2.37 B | $5.19 B |
| US-listed rank | #1977 | #1359 |
| Revenue (latest FY) | $1.17B | $1.04B |
| Net income (latest FY) | -$167.10M | $154.85M |
| Net margin | -14.3% | 14.9% |
| P/E (trailing FY) | - | 33.5 |
| SEC filings | 636 | 1,267 |
BALCHEM CORP is 2.2x more valuable than Ingevity Corp by market capitalization ($5.19 B vs $2.37 B).
In their latest fiscal years, Ingevity Corp reported $1.17B in revenue while BALCHEM CORP reported $1.04B.
Full pages: Ingevity Corp and BALCHEM CORP, or browse the full rankings.